• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 ARTISSE; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 ARTISSE; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Model Number ISF-055-040
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Paralysis (1997); Paresis (1998); Irritability (2421); Confusion/ Disorientation (2553); Ischemia Stroke (4418)
Event Date 03/26/2024
Event Type  Injury  
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
Medtronic received a report that an artisse patient experienced left hemibody deficit.The patient was being treated for a right ica c6 aneurysm with a saccular morphology in the terminus vessel.Aneurysm dimensions: max diameter 3.6 mm and neck diameter 3.3 mm, dome height 6.1 mm and dome width 2.9 mm.Parent artery diameter distal to aneurysm: 2.4 mm.Parent artery diameter proximal to aneurysm: 5.9 mm.Ae result in the subject being hospitalized or a prolongation of an existing hospitalization.Mdt assessment: possibly related to index procedure, artisse device, not related to ancillary device or dapt.Post implant there was significant stasis.The patient recovered/resolved on (b)(6) 2024.
 
Event Description
Additional information was received that medtronic received a report that the patient experienced a right sylvian ischemic stroke with parieto-occipital hemorrhagic rearrangement post procedure.The event resulted in new or worsening of existing neurological deficits and symptoms last for more than 24 hours.They had confusion and left hemiparesis, logorrhea, agitation and facial paralysis.The event resulted in new hospitalization from (b)(6) 2024.Concomitant or additional treatment was given.The event recovered/resolved with sequalae on 2024-may-02.The event was noted as possibly related to the disease under study.The sponsor assessed the event as possibly related to the artisse device and not related to the index procedure, ancillary device, or dapt.The site assessed as possibly related to the device and ancillary device, causally related to the procedure, and not related to dapt.***us mdr decision corrected to not reportable as device is not marketed or similar device in us.No additional supplemental reports are required unless additional information received indicates reportable event.
 
Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTISSE
Type of Device
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key19172834
MDR Text Key340924999
Report Number2029214-2024-00733
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 05/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberISF-055-040
Device Catalogue NumberISF-055-040
Device Lot NumberB563311
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 04/17/2024
Initial Date FDA Received04/24/2024
Supplement Dates Manufacturer Received05/08/2024
Supplement Dates FDA Received05/10/2024
Date Device Manufactured05/12/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age74 YR
Patient SexFemale
Patient Weight54 KG
-
-